Health Care Reform & Industry Outlook - Equity Research on Orthovita, Inc. and Johnson & Johnson
17 5월 2011 - 10:00PM
Marketwired
Today, www.WorldStreetFundamentals.com released its industry report
highlighting Orthovita, Inc. (NASDAQ: VITA) and Johnson &
Johnson (NYSE: JNJ). Full fundamental and technical analysis is
available at www.WorldStreetFundamentals.com/Reports.php.
Preliminary thoughts from industry analysts expect recent health
care reform legislation to negatively affect industry profitability
over the next few years, offset by eventual benefits accruing from
significant expansion of the market, with new coverage potentially
being provided to 31.9 million currently uninsured Americans. With
this in mind, investors are favoring shares of firms with
well-defined growth prospects and generous dividend yields, as
general consensus expects relatively good performance of such
equities over the coming quarters.
The pharmaceutical industry remains one of the widest-margin
U.S. industries, with prospects enhanced by demographic growth in
the elderly and new drugs stemming from discoveries in genomics and
biotechnology. As such, long term fundamentals remain favorable as
additional longer-range benefits from cost restructurings and
merger synergies are anticipated.
World Street Fundamentals has highlighted Orthovita for its
focus as a specialty spine and orthopedic company with a portfolio
of orthobiologic and biosurgery products. Its orthobiologic
platform includes products for the fusion, regeneration and
fixation of human bone. Its orthobiologic products are based on its
Vitoss Bone Graft Substitute technology and include the Imbibe Bone
Marrow Aspiration System used with Vitoss. Its orthobiologic
products also include Cortoss Bone Augmentation Material and the
Aliquot Delivery System used with Cortoss. The entire report on
Orthovita, Inc. (NASDAQ: VITA) is available here:
www.WorldStreetFundamentals.com/ViewFullReport.245.php.
World Street has highlighted Johnson & Johnson for its
engagement in the research and development, manufacture and sale of
a range of products in the health care field. It has more than 250
operating companies conducting business worldwide. The Company's
operating companies are organized into three business segments:
Consumer, Pharmaceutical and Medical Devices and Diagnostics. The
Company and its subsidiaries operate 139 manufacturing facilities
occupying approximately 21.8 million square feet of floor space.
The entire report on Johnson & Johnson (NYSE: JNJ) is available
here: www.WorldStreetFundamentals.com/ViewFullReport.138.php.
About World Street World Street Fundamentals is an online portal
for professionals, investors and new-comers to the markets to find
in depth comprehensive research and research tools to help guide
you through the ever changing financial markets. Covering the top
performers in the hottest sectors and providing clarity to
investors around the world.
Contact: Adam Redford Email Contact
www.WorldStreetFundamentals.com
Orthovita, Inc. (MM) (NASDAQ:VITA)
과거 데이터 주식 차트
부터 5월(5) 2024 으로 6월(6) 2024
Orthovita, Inc. (MM) (NASDAQ:VITA)
과거 데이터 주식 차트
부터 6월(6) 2023 으로 6월(6) 2024
Orthovita, Inc. (MM) (나스닥)의 실시간 뉴스: 최근 기사 0
More World Street Fundamentals News Articles